3D printing is defined as a computerized or automated process for manufacturing medical devices, prototypes and implants. It exploits a layer-by-layer accumulation technique to produce substantial objects from a three-dimensional digital file, also known as additive manufacturing. It helps surgeons to improve the success rate of dense procedures. Additionally, this technology has transformed preclinical drug testing by facilitating testing on 3D printed organs.
Some components of the 3D printer are a nozzle, power supply, threaded rods or lead screws, enclosure, idler gear, bed leveling, user interface, thermistor, filament, frame, motherboard, hobbed gear, stepper drivers, extruder, layer cooling fan, and stepper motors etc.
According to study, “Asia-Pacific 3D Printing in Healthcare Market (2018-2023)” some of the major companies that are currently working in the Asia-Pacific 3D printing in healthcare market are Stratasys Ltd., Renishaw, KCbots, Imaginarium, JGroup Robotics, Brahma 3, Altem Technologies, Organovo, Formlabs, Cellink.
On the basis of type, the 3D printing in the healthcare market is segmented into implants, hearing aid, prosthetics and surgical guides. On the basis of material, the market is segmented into metal & alloys, polymers, biological cells and ceramic etc. Metal & alloys are further sub-segmented into titanium, silver, steel, and gold. A polymer is sub-segmented into epoxy resins, nylon and glass filled polyamide. On the basis of technology, the market is segmented into electron beam melting (EBM), stereolithography, deposition modeling, laser beam melting (LBM), droplet deposition, jetting technology, photopolymerization, and laminated object manufacturing etc. In addition, on the basis of application, the market is segmented into prosthetics, tissue engineering, medical implants, and wearable devices and many others.
The Asia-Pacific 3D printing healthcare market is driven by factors such as increasing technological advancements, increasing disposable income, increasing dental laboratories& hearing aid manufacturers, increasing scope of bioengineering products, rising demand for patient-centric products in orthopedics &maxillofacial surgery, the reduction in the costs of 3D models and the availability of a range of material options such as nylon, polymers, etc.
Some of the major advantages include complex shape, rapid prototyping, and easy to use, clean process and reduce design complexity. Some disadvantages are a slow process, being expensive. Additionally, some of the major challenges include the high cost of 3D printed organs & tissue, lack of regulatory issues and trained professionals.
The National Additive Manufacturing Innovation Cluster (NAMIC) is a pan-national initiative of Singapore. The main aim of this initiative is to increase the adoption of additive manufacturing technologies to improve competitiveness in the fast developing landscape of digital industrialization. The China Food and Drug Administration (CFDA) is a government regulatory authority in China, which provides specific requirements for validation of additive manufacturing products of 3D printing medical devices.
South Korea, Singapore, Japan, and China are some countries of this region, which are accountable for driving the 3D printing in the healthcare industry due to an increasing focus on bio-printing. Additionally, Japan and India, along with China, have privileged potential because of importance on 3D printing of orthopedic tackle, which provides to the augmented demand from the aged population.
It is estimated that Asia-Pacific 3D printing in the healthcare market will reach at US$ 0.59 billion by 2023.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications